ORGO

Organogenesis Holdings Inc.

NASDAQHealthcareDrug Manufacturers - Specialty & GenericUS

USD2.68

+0.05 (+1.90%)

Rating:C+

Company Profile

CEO

Gary S. Gillheeney

IPO Date

2017-01-05

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

Country

Market Metrics

Open

$2.63

Prev. Close

$2.63

Day Low

$2.62

Day High

$2.69

52W Low

$2.04

52W High

$7.08

Market Cap

$0.34B

Volume

0.52M

News SentimentNeutral

Articles

Avg Positive

15.0%

Avg Negative

6.9%

Avg Neutral

78.0%

News Feed

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2021 Financial Results on August 9, 2021

GlobeNewsWire·7/2/2021·↑ positive

Why Organogenesis Holdings Blasted 7.7% Higher Today

The Motley Fool·5/27/2021·↑ positive

Organogenesis Holdings Inc. (ORGO) CEO Gary Gillheeney on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/11/2021·↓ negative